We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$174M
AUM Growth
+$15.3M
Cap. Flow
+$869K
Cap. Flow %
0.5%
Top 10 Hldgs %
22.23%
Holding
180
New
23
Increased
31
Reduced
71
Closed
28

Top Buys

Rank Stock Value
1
EQT icon
EQT Corp
EQT
+$1.79M
2
J icon
Jacobs Solutions
J
+$1.54M
3
AMGN icon
Amgen
AMGN
+$1.42M
4
PB icon
Prosperity Bancshares
PB
+$1.37M
5
LNG icon
Cheniere Energy
LNG
+$1.33M

Top Sells

Rank Stock Value
1
DE icon
Deere & Co
DE
+$1.42M
2
FANG icon
Diamondback Energy
FANG
+$1.32M
3
VLO icon
Valero Energy
VLO
+$1.14M
4
EOG icon
EOG Resources
EOG
+$1.04M
5
ARW icon
Arrow Electronics
ARW
+$945K

Sector Composition

Rank Sector Weight
1 Industrials 22.1%
2 Healthcare 18.51%
3 Consumer Staples 13.38%
4 Financials 13.17%
5 Technology 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REXR icon
101
Rexford Industrial Realty
REXR
$8.61B
$571K 0.33%
10,450
-3,650
-26% -$197K
LLY icon
102
Eli Lilly
LLY
$1.01T
$547K 0.31%
1,495
ECL icon
103
Ecolab
ECL
$77B
$546K 0.31%
+3,750
New +$551K
PNR icon
104
Pentair
PNR
$9.03B
$523K 0.3%
11,625
-200
-2% -$8.7K
APA icon
105
APA Corp
APA
$16.6B
$499K 0.29%
+10,700
New +$479K
BA icon
106
Boeing
BA
$166B
$498K 0.29%
2,613
V icon
107
Visa
V
$701B
$497K 0.29%
2,390
AMD icon
108
Advanced Micro Devices
AMD
$823B
$468K 0.27%
7,226
-3,410
-32% -$225K
AZN icon
109
AstraZeneca
AZN
$251B
$464K 0.27%
3,425
CCI icon
110
Crown Castle
CCI
$31.2B
$464K 0.27%
3,420
+1,070
+46% +$145K
UNH icon
111
UnitedHealth
UNH
$337B
$464K 0.27%
+875
New +$463K
WPC icon
112
W.P. Carey
WPC
$15.6B
$464K 0.27%
6,062
+230
+4% +$17.3K
CNI icon
113
Canadian National Railway
CNI
$73.7B
$445K 0.26%
3,740
-6,530
-64% -$781K
EMR icon
114
Emerson Electric
EMR
$82B
$444K 0.26%
4,623
IDXX icon
115
Idexx Laboratories
IDXX
$40.2B
$439K 0.25%
1,075
-1,425
-57% -$553K
WCN
116
Waste Connections
WCN
$40.1B
$434K 0.25%
+3,274
New +$445K
WMT icon
117
Walmart Inc
WMT
$858B
$428K 0.25%
9,048
-7,260
-45% -$345K
HOLX
118
DELISTED
Hologic
HOLX
$417K 0.24%
5,575
+75
+1% +$5.34K
LDOS icon
119
Leidos
LDOS
$16.2B
$396K 0.23%
3,763
-7,400
-66% -$758K
QSR icon
120
Restaurant Brands International
QSR
$26.3B
$391K 0.22%
6,049
SYK icon
121
Stryker
SYK
$108B
$391K 0.22%
+1,601
New +$363K
MRVL icon
122
Marvell Technology
MRVL
$199B
$382K 0.22%
10,320
+5
+0% +$204
GE icon
123
GE Aerospace
GE
$319B
$368K 0.21%
7,054
-910
-11% -$44.7K
DAR icon
124
Darling Ingredients
DAR
$10.5B
$361K 0.21%
5,775
-3,100
-35% -$219K
MXL icon
125
MaxLinear
MXL
$6.09B
$345K 0.2%
+10,150
New +$344K

Similar funds

New England Research & Management's Q4 2022 Portfolio in Review

As of Q4 2022, New England Research & Management held 180 positions worth $174M, up 9.6% from $159M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

New England Research & Management's Q4 2022 filing shows 23 new, 31 increased, 71 reduced and 28 closed positions. Its largest new stake was Amgen: 5,280 shares worth $1.39M. The largest sale was Deere & Co, an estimated $1.42M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q4 2022 buy was Amgen: 5,280 shares worth $1.39M.
  • New England Research & Management added most to EQT Corp in Q4 2022, an estimated $1.79M increase.
  • New England Research & Management's biggest Q4 2022 reduction was Deere & Co, cutting an estimated $1.42M.
  • New England Research & Management fully exited Diamondback Energy in Q4 2022, selling an estimated $1.32M.
  • New England Research & Management's ten largest holdings make up 22% of its $174M portfolio in Q4 2022.
  • New England Research & Management opened 23 new positions and closed 28 in Q4 2022.
  • New England Research & Management's portfolio value rose 9.6% quarter-over-quarter to $174M.

Based on New England Research & Management's 13F filing for Q4 2022, filed 9 Jan 2023.